ICAGEN (NASDAQ:ICGN)
0.45
0.03 (6.25%)
| ICAGEN (NASDAQ:ICGN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $0.48 | 52 Week High | $1.59 | ||
| Open | $0.45 | 52 Week Low | $0.31 | ||
| Day High | $0.47 | P/E | N/A | ||
| Day Low | $0.45 | EPS | $-0.28 | ||
| Volume | 4,500 | ||||
| More ICGN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| PFE | 3 | EDAP | 2 |
| DTG | 2 | SVA | 2 |
| BEXP | 2 | GNVC | 2 |
| UCTT | 2 | HMA | 2 |
| BLDR | 2 | MBRK | 2 |
| ACAD | 2 | ARE | 2 |
Entities who have mentioned ICGN
- Bakken Formation | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Sanford C. Bernstein | View Related Stories »
- Warburg Pincus | View Related Stories »
- Deutsche Bank | View Related Stories »
- UBS | View Related Stories »
- Morgan Stanley | View Related Stories »
- Barclays | View Related Stories »
- Morgan Keegan & Company | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- GLG Partners | View Related Stories »
- Trading Radar | View Related Stories »
- Layoffs | View Related Stories »
- Citi | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- RBC Capital | View Related Stories »
- Credit Suisse | View Related Stories »
- Robert W Baird | View Related Stories »
- BMO Capital | View Related Stories »
- JMP Securities | View Related Stories »
- After-Hours Movers | View Related Stories »
- William Blair | View Related Stories »
- Carl Icahn | View Related Stories »
StreetInsider.com Major News for ICGN
View All ReportsStreetInsider.com Reports on ICGN
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Morning Movers 10/27: HPGP, HLND, TBAC, CTDC, PODD, HSII Higher; ICGN, AMFI, IBCP, CRI, SGMS, PVTB Lower
- After-Hours Movers 10/26: ENTR, UCTT, LULU, IVAC, TBAC Higher; ICGN, ZRAN, BIDU, WINN, LTD Lower
- Icagen (ICGN) Senicapoc Fails In Phase IIa Study
- Icagen (ICGN) Presented Data Found in Collaboration with Pfizer (PFE) to Identify Sodium Channel Modulators
View All Press ReleasesCompany Press Releases on ICGN
- Icagen Reports Receipt of Notification from NASDAQ Regarding Non-Compliance With Continued Listing Requirements
- Icagen Reports Third Quarter 2009 Financial Results and Operational Highlights
- Icagen Reports Top-line Results of Phase IIa Study of Senicapoc in Exercise-Induced Asthma
- Icagen to Report Third Quarter 2009 Results on November 5, 2009
- Icagen to Present at Eighth Annual Bio Investor Forum
StreetInsider Reports on ICGN by Category
View All BlogsBlogs on ICGN
- Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
- 11 Ache-free Investment Opportunities in Neuropathic Pain
- Potential Profit from Fall Allergy Season
- FDA Calendar Updates: Transcept Pharma Surges on Deal
- Analyst initiations: Cougar Biotech, Icagen and SuccessFactors
View All FilingsSEC Filings on ICGN
- Form 8-K ICAGEN INC For: Nov 12
- Form 10-Q ICAGEN INC For: Sep 30
- Form 8-K ICAGEN INC For: Nov 05
- Form 4 ICAGEN INC For: Nov 02 Filed by: Katz Richard D
- Form 8-K ICAGEN INC For: Oct 26
Comments on ICGN
No comments are currently available.
